EUCTR2006-001927-20-IT进行中（未招募）不适用
Treatment with Anakinra in TRAPS - ND
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with molecular diagnosis of TRAPS with
- •1) more than 2 episodes/year lasting at least one week with limitation of normal daily activities
- •2) chronic disease course with steroid dependence and/or limitation of normal daily activities
- •3) Persistently high level of SAA in at least 3 determinations in the presence of 24h proteinuria
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1.Immunosuppressive treatment in the 6 week before
- •2. Ongoing infections
- •3. Positive history for drug-resistent TBC
- •4. Active TBC
- •5. Positive PPD test at the time of enrollment
- •6. Low white cell count (<1.5x106/l) or thrombocytopenia (<150,000/mm3) 7. Liver enzymes 3 times above the normal range
- •8. Pregnancy
研究者
相似试验
招募中
不适用
TERAPIA CON LASER TRANSCRANEAL INFRARROJO CERCANO EN SUJETOS CON TRASTORNO DEPRESIVO MAYOR: UN ESTUDIO DE DOSIFICACION CON LASER-F32F32PER-035-20iteCure LLC.,
进行中（未招募）
1 期
altrexone Enhanced Addiction Treatment (NEAT): A randomised controlled trial of the clinical and cost-effectiveness of extended-release naltrexone and oral naltrexoneEUCTR2013-002584-25-GBKing's College London6
尚未招募
3 期
ong-Acting Treatment in Adolescents (LATA)HIV/AIDSPACTR202302484199604niversity College London460
尚未招募
2 期
ANTERN - LAser Nerve ThERapy for chemotherapy NeurotoxicitycancerACTRN12619001672145Concord Cancer Centre45
进行中（未招募）
不适用
A randomised study with Cisplatinum or Cetuximab and standard or adaptive high dose radiotherapy for advanced head and neck cancerExplore the impact of pre-treatment information and dose redistribution on locoregional control in patients with locally advanced SCCHN.ARREGLAREUCTR2012-000437-39-ESStichting Antoni van Leeuwenhoek Ziekenhuis268